Document is current
Any future updates will be listed below
-
Authors
Hanna, Paul E. https://orcid.org/0000-0003-4976-9104
Strohbehn, Ian A.
Moreno, Daiana
Harden, Destiny
Seethapathy, Rituvanthikaa
Sawtell, Rani
Wang, Qiyu
Ouyang, Tianqi
Katz-Agranov, Nurit
Dinulos, James
Wander, Seth A.
Gupta, Shruti
Sise, Meghan E.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK130839)
- License Information
-
More Information
Article History
Received: 21 December 2022
Accepted: 10 August 2023
First Online: 19 August 2023
Competing interests
: P.E.H., I.A.S., D.M., D.H., R.S., R.S., Q.W., T.O., N.K. and J.D. have nothing to disclose. S.G. receives research funding from BTG International and GE Healthcare. S.G. serves as a consultant for GlaxoSmithKline and Secretome. S.W. serves on the consulting/advisory board of the following organizations: Foundation Medicine, Veracyte, Hologic, Pfizer, Eli Lilly, Biovica; Institutional research support: Genentech, Eli Lilly, Nuvation Bio, and Regor Therapeutics. M.E.S. has research funding from Gilead, Abbvie, Otsuka, Angion, and EMD Serono. M.E.S. has served on an advisory board for Vera, Novartis, Travere, and Malinckrodt, and she is a Data Monitoring Committee Member for Alpine Immunosciences.
